Next-gen intranasal Measles/Mumps-vectored vaccine platform for robust protection against SARS-CoV-2 and RSV
TS-075190 — PROBLEM
SARS-CoV-2, particularly the emerging Omicron variants, and respiratory syncytial virus (RSV) propose significant threat to global public health. Both SARS-CoV-2 and RSV are highly transmissible and significant risk of disease in infants and young children, older adults, and immunocompromis…
- College: College of Veterinary Medicine
- Inventors: Li, Jianrong; Hsu, Cheng
Chih; Liang, Xueya
- Licensing Officer: Willson, Christopher
